Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients Clinical research trials and A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients. A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients clinical trial. Participants oftentimes recieve the finest healthcare available for their A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients

A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients



A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients

For Condition: HIV Infections
Status: Completed
Sponsor(s): Merck Research Laboratories ,
Synopsis: The purpose of this study is to see if it is safe and effective to give indinavir sulfate plus stavudine to HIV-infected patients who have already been treated with zidovudine.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Double-Blind, Safety Study
Minimum Age/Maximum Age: 18 Years/60 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Concurrent Medication: Allowed: - Prophylaxis with aerosolized pentamidine, topical antifungals, TMP / SMX, dapsone, or isoniazid. Patients must have: - HIV infection. - CD4 count 50 - 500 cells/mm3. - Prior AZT use for more than 6 months OR documented intolerance to AZT with more than 6 months use of another anti-HIV therapy other than d4T or any protease inhibitor. - No active opportunistic infection or visceral Kaposi's sarcoma. NOTE: - Patients with hemophilia may be enrolled at discretion of investigator. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Symptomatic neuropathy. - Acute hepatitis. Concurrent Medication: Excluded: - Antiretrovirals other than specified in protocol. - Chronic therapy for an active opportunistic infection. - Immunosuppressive therapy. Prior Medication: Excluded: - Any prior protease inhibitor or d4T. - Any nucleoside analogs within 2 weeks prior to study entry. - Investigational agents or immunomodulators within 30 days prior to study entry. Required: - More than 6 months of prior AZT unless intolerant, in which case more than 6 months of another anti-HIV therapy (other than protease inhibitors or d4T).
Total Enrollment: 540

Location and Contact Information:

Merck & Co Inc
Whitehouse Station,  New Jersey,  088890100
United States
 


Additional Information:
Study ID Numbers:  246D;  37
Study Start Date: 
Record last reviewed: January 1996
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002354

Other Hiv Infections Studies:
1. Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.

2. The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants

3. Open, Non-comparative Study of Fluconazole in Patients With Coccidioidal Meningitis

4. A Study of ddC in Patients with AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success with Zidovudine (AZT)

5. The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients with AIDS and Advanced ARC

Related Studies:

Other HIV Infections Clinical Trials
Other New Jersey Clinical Trials
Other Whitehouse Station Clinical Trials

A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients
Modify your Search

  Other HIV Infections Clinical Trials
  Other New Jersey Clinical Trials
  Other Whitehouse Station Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103